Oruka Therapeutics (ORKA) EBT (2010 - 2024)
Oruka Therapeutics' (ORKA) quarterly EBT came in at -$18.1 million in Q2 2024, down 1085.44% year-on-year from $1.8 million in Q3 2023, and down 157.93% quarter-over-quarter from -$7.0 million in Q1 2024.
Oruka Therapeutics (ORKA) EBT (2010 - 2024) Analysis & Trends
Oruka Therapeutics' EBT history runs 15 years deep, the most recent figure standing at -$18.1 million for Q2 2024.
- On a quarterly basis, EBT fell 1085.44% year-over-year to -$18.1 million in Q2 2024; TTM through Jun 2024 was -$28.0 million, a 332.04% decrease from a year earlier, with the FY2023 full-year figure at -$60.9 million, up 5.32% from the prior year.
- EBT declined to -$18.1 million in Q2 2024 per ORKA's latest filing, from -$7.0 million in the prior quarter.
- Across five years, EBT topped out at -$1.1 million in Q4 2023 and bottomed at -$18.1 million in Q2 2024.
- The 5-year median for EBT is -$2.8 million (2022), against an average of -$3.9 million.
- Across the five-year window, EBT soared 79.32% in 2022 and plunged 1085.44% in 2024, its largest moves.
- Year by year, EBT stood at -$5.1 million in 2020, then fell by 10.75% to -$5.7 million in 2021, then surged by 79.32% to -$1.2 million in 2022, then rose by 5.03% to -$1.1 million in 2023, then sank by 1521.35% to -$18.1 million in 2024.
- Per Business Quant, the three latest ORKA EBT figures stand at -$18.1 million (Q2 2024), -$7.0 million (Q1 2024), and -$1.1 million (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -18.08 Mn |
| Mar 31, 2024 | -7.01 Mn |
| Dec 31, 2023 | -1.12 Mn |
| Sep 30, 2023 | -1.76 Mn |
| Jun 30, 2023 | -1.53 Mn |
| Mar 31, 2023 | -1.38 Mn |
| Dec 31, 2022 | -1.17 Mn |
| Sep 30, 2022 | -2.40 Mn |
| Jun 30, 2022 | -3.65 Mn |
| Mar 31, 2022 | -3.30 Mn |
| Dec 31, 2021 | -5.68 Mn |
| Sep 30, 2021 | -4.71 Mn |
| Jun 30, 2021 | -4.83 Mn |
| Mar 31, 2021 | -4.11 Mn |
| Dec 31, 2020 | -5.13 Mn |
| Sep 30, 2020 | -1.99 Mn |
| Jun 30, 2020 | -1.31 Mn |
| Mar 31, 2020 | -1.32 Mn |
| Dec 31, 2019 | -1.24 Mn |
| Sep 30, 2019 | -1.20 Mn |